fda compounding glp-1 warning letters october 2025 Sends to More Than 50 Compounders and Manufacturers FDA issued 25 warning letters

This can increase the likelihood of patients adjusting their dose and deviating from the prescribed regimen in order to manage the associated discomfort

This article demonstrates the efficacy of tirzepatide for treatment of MASH

DiGruccio MR, Mawla AM, Donaldson CJ et al (2016) Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets

Tardif JC, Kouz S, Waters David D, Bertrand OF et al (2019) Efficacy and safety of low-dose colchicine after myocardial infarction

Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as an Add-on to Metformin, Thiazolidinediones, or Both, in Patients With Type 2 Diabetes (SUSTAIN 2): A 56-Week, Double-Blind, Phase 3a, Randomised Trial

Exchange transfusion may be especially useful in complex cases (e.g., pregnancy plus G6PD deficiency) because it will be effective regardless of the medical complexities of the situation